These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 1186792)
1. Editorial: Cancer risk and estrogen use in the menopause. Ryan KJ N Engl J Med; 1975 Dec; 293(23):1199-200. PubMed ID: 1186792 [TBL] [Abstract][Full Text] [Related]
2. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician. Berger GS; Fowler WC J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Risks and benefits of estrogen use. Weiss NS N Engl J Med; 1975 Dec; 293(23):1200-2. PubMed ID: 1186793 [TBL] [Abstract][Full Text] [Related]
5. Doubts about oestrogen therapy in postmenopausal women. Res Reprod; 1976 Jan; 8(1):1-2. PubMed ID: 12258712 [TBL] [Abstract][Full Text] [Related]
6. The adverse effects of hormonal therapy. Bush TL Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931 [TBL] [Abstract][Full Text] [Related]
7. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
8. Review of epidemiologic studies of endometrial cancer and exogenous estrogen. Cramer DW; Knapp RC Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641 [TBL] [Abstract][Full Text] [Related]
9. Estrogen use in postmenopausal women. Kaunitz AM N Engl J Med; 1980 Dec; 303(25):1477-8. PubMed ID: 7432409 [TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer and estrogen use. Report of a large case-control study. Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722 [TBL] [Abstract][Full Text] [Related]
11. Estrogen use and postmenopausal women. United States. National Institute on Aging NIH Consens Dev Conf Summ; 1979; 2(8):1-5. PubMed ID: 12336054 [TBL] [Abstract][Full Text] [Related]
12. The prevention of breast cancer through reduced ovarian steroid exposure. Spicer DV; Pike MC Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631 [TBL] [Abstract][Full Text] [Related]
13. Sex steroids and cancer. Gambrell RD Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519 [TBL] [Abstract][Full Text] [Related]
14. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related]
15. Endogenous and exogenous endocrine factors. Henderson BE Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490 [TBL] [Abstract][Full Text] [Related]
16. Menopausal estrogens and breast cancer. Hoover R; Gray LA; Cole P; MacMahon B N Engl J Med; 1976 Aug; 295(8):401-5. PubMed ID: 180409 [TBL] [Abstract][Full Text] [Related]